235 related articles for article (PubMed ID: 23231648)
1. "Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.
Sun X; Jiang R; Przepiorski A; Reddy S; Palmano KP; Krissansen GW
BMC Cancer; 2012 Dec; 12():591. PubMed ID: 23231648
[TBL] [Abstract][Full Text] [Related]
2. 'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy.
Kanwar JR; Palmano KP; Sun X; Kanwar RK; Gupta R; Haggarty N; Rowan A; Ram S; Krissansen GW
Immunol Cell Biol; 2008; 86(3):277-88. PubMed ID: 18268518
[TBL] [Abstract][Full Text] [Related]
3. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice.
Kim EJ; Choi MR; Park H; Kim M; Hong JE; Lee JY; Chun HS; Lee KW; Yoon Park JH
Breast Cancer Res; 2011 Aug; 13(4):R78. PubMed ID: 21834963
[TBL] [Abstract][Full Text] [Related]
4. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.
Shou J; Massarweh S; Osborne CK; Wakeling AE; Ali S; Weiss H; Schiff R
J Natl Cancer Inst; 2004 Jun; 96(12):926-35. PubMed ID: 15199112
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.
Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J
Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
[TBL] [Abstract][Full Text] [Related]
8. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
9. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
10. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
[TBL] [Abstract][Full Text] [Related]
11. Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.
Zhang X; Cook KL; Warri A; Cruz IM; Rosim M; Riskin J; Helferich W; Doerge D; Clarke R; Hilakivi-Clarke L
Clin Cancer Res; 2017 Feb; 23(3):814-824. PubMed ID: 28148690
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
Takei H; Lee ES; Cisneros A; Jordan VC
Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
[TBL] [Abstract][Full Text] [Related]
13. A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth.
Restall C; Doherty J; Liu HB; Genovese R; Paiman L; Byron KA; Anderson RL; Dear AE
Int J Cancer; 2009 Jul; 125(2):483-7. PubMed ID: 19330834
[TBL] [Abstract][Full Text] [Related]
14. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
[TBL] [Abstract][Full Text] [Related]
15. The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
Mazumdar A; Medina D; Kittrell FS; Zhang Y; Hill JL; Edwards DE; Bissonnette RP; Brown PH
Cancer Prev Res (Phila); 2012 Oct; 5(10):1195-202. PubMed ID: 22926341
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
Moi LL; Flågeng MH; Gjerde J; Madsen A; Røst TH; Gudbrandsen OA; Lien EA; Mellgren G
BMC Cancer; 2012 Jun; 12():247. PubMed ID: 22703232
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines.
Smart E; Alejo LH; Frasor J
Horm Cancer; 2020 Apr; 11(2):76-86. PubMed ID: 32008217
[TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Jpn J Cancer Res; 1997 Feb; 88(2):184-90. PubMed ID: 9119747
[TBL] [Abstract][Full Text] [Related]
19. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
